Use of CMV unselected blood products does not increase the risk of CMV reactivation in patients undergoing hematopoetic stem cell transplant (HSCT).
Somervaille, Tim C P
Sommerfeld, Sven A
Mamat, Mohd K
AffiliationThe Christie NHS Foundation Trust, Manchester